Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Slassi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Bioorganic & Medicinal Chemistry|April 20, 2001
Imidazoline-modified benzylimidazolines as h5-HT(1D/1B) serotonergic ligandsT Prisinzano, H Law, M Dukat, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2001
5,5-Diaryl-2-amino-4-pentenoates as novel, potent, and selective glycine transporter type-2 reuptake inhibitorsM Isaac, A Slassi, K D Silva, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
6-Bicyclopiperazinyl-1-arylsulfonylindoles and 6-bicyclopiperidinyl-1-arylsulfonylindoles derivatives as novel, potent, and selective 5-HT6 receptor antagonistsM Isaac, A Slassi, T Xin, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2000
5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: potential treatments for migraineC Q Meng, S Rakhit, D K Lee, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonistsY Tsai, M Dukat, A Slassi, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2000
Pyrrolo[3,2,1-ij]quinoline derivatives, a 5-HT2c receptor agonist with selectivity over the 5-HT2a receptor: potential therapeutic applications for epilepsy and obesityM Isaac, A Slassi, A O'Brien, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
5-Alkyltryptamine derivatives as highly selective and potent 5-HT1D receptor agonistsA Slassi, L Edwards, A O'Brien, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Bioorganic & Medicinal Chemistry|April 20, 2001
Imidazoline-modified benzylimidazolines as h5-HT(1D/1B) serotonergic ligandsT Prisinzano, H Law, M Dukat, et al.
Bioorganic & Medicinal Chemistry Letters|May 30, 2001
5,5-Diaryl-2-amino-4-pentenoates as novel, potent, and selective glycine transporter type-2 reuptake inhibitorsM Isaac, A Slassi, K D Silva, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
6-Bicyclopiperazinyl-1-arylsulfonylindoles and 6-bicyclopiperidinyl-1-arylsulfonylindoles derivatives as novel, potent, and selective 5-HT6 receptor antagonistsM Isaac, A Slassi, T Xin, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2000
5-Thienyltryptamine derivatives as serotonin 5-HT1B/1D receptor agonists: potential treatments for migraineC Q Meng, S Rakhit, D K Lee, et al.
Bioorganic & Medicinal Chemistry Letters|October 31, 2000
N1-(Benzenesulfonyl)tryptamines as novel 5-HT6 antagonistsY Tsai, M Dukat, A Slassi, et al.
Bioorganic & Medicinal Chemistry Letters|June 15, 2000
Pyrrolo[3,2,1-ij]quinoline derivatives, a 5-HT2c receptor agonist with selectivity over the 5-HT2a receptor: potential therapeutic applications for epilepsy and obesityM Isaac, A Slassi, A O'Brien, et al.
Bioorganic & Medicinal Chemistry Letters|August 11, 2000
5-Alkyltryptamine derivatives as highly selective and potent 5-HT1D receptor agonistsA Slassi, L Edwards, A O'Brien, et al.
Pageof 1